Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W1FM
|
|||
| Former ID |
DNC010184
|
|||
| Drug Name |
4-(3H-indol-4-ylamino)-5-styrylnicotinonitrile
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H16N4
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C=CC2=CN=CC(=C2NC3=CC=CC4=C3C=CN4)C#N
|
|||
| InChI |
1S/C22H16N4/c23-13-18-15-24-14-17(10-9-16-5-2-1-3-6-16)22(18)26-21-8-4-7-20-19(21)11-12-25-20/h1-12,14-15,25H,(H,24,26)/b10-9+
|
|||
| InChIKey |
HETWGNHMXYNQPB-MDZDMXLPSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | First generation 5-vinyl-3-pyridinecarbonitrile PKCtheta inhibitors. Bioorg Med Chem Lett. 2009 Oct 15;19(20):5829-32. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.